The economic burden of TB diagnosis and treatment in South Africa  by Foster, Nicola et al.
lable at ScienceDirect
Social Science & Medicine 130 (2015) 42e50Contents lists avaiSocial Science & Medicine
journal homepage: www.elsevier .com/locate/socscimedThe economic burden of TB diagnosis and treatment in South Africa
Nicola Foster a, *, Anna Vassall b, Susan Cleary a, Lucy Cunnama a, Gavin Churchyard c, d,
Edina Sinanovic a
a Health Economics Unit, School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Anzio Road,
Observatory 7925, South Africa
b Social and Mathematical Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom
c Aurum Institute, Queens Road, Parktown, Johannesburg, South Africa
d Department of Clinical Research, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdoma r t i c l e i n f o
Article history:
Available online 27 January 2015
Keywords:
South Africa
Patient costs
Tuberculosis
Costing
Diagnosis
Treatment
Catastrophic costs
Economic burden* Corresponding author. Health Economics Unit,
Family Medicine, Falmouth Annex, Medical Campus, U
Road, Observatory 7925, South Africa.
E-mail address: Nicola.Foster@uct.ac.za (N. Foster)
http://dx.doi.org/10.1016/j.socscimed.2015.01.046
0277-9536/© 2015 The Authors. Published by Elseviera b s t r a c t
Social protection against the cost of illness is a central policy objective of Universal Health Coverage and
the post-2015 Global strategy for Tuberculosis (TB). Understanding the economic burden associated with
TB illness and care is key to identifying appropriate interventions towards achieving this target. The aims
of this study were to identify points in patient pathways from start of TB symptoms to treatment
completion where interventions could be targeted to reduce the economic impact on patients and
households, and to identify those most vulnerable to these costs.
Two cohorts of patients accessing TB services from ten clinics in four provinces in South Africa were
surveyed between July 2012 and June 2013. One cohort of 351 people with suspected TB were inter-
viewed at the point of receiving a TB diagnostic and followed up six months later. Another cohort of 168
patients on TB treatment, at the same ten facilities, was interviewed at two-months and ﬁve-months on
treatment. Patients were asked about their health-seeking behaviour, associated costs, income loss, and
coping strategies used.
Patients incurred the greatest share of TB episode costs (41%) prior to starting treatment, with the
largest portion of these costs being due to income loss. Poorer patients incurred higher direct costs
during treatment than those who were less poor but only 5% of those interviewed were accessing cash-
transfers during treatment. Indirect costs accounted for 52% of total episode cost.
Despite free TB diagnosis and care in South Africa, patients incur substantial direct and indirect costs
particularly prior to starting treatment. The poorest group of patients were incurring higher costs, with
fewer resources to pay for it. Both the direct and indirect cost of illness should be taken into account
when setting levels of ﬁnancial protection and social support, to prevent TB illness from pushing the poor
further into poverty.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Social protection against the cost of illness is a central policy
objective of Universal Health Coverage and correspondingly the
post-2015 Global strategy for Tuberculosis (TB) (World Health
Organisation, 2015). Social protection strategies include access to
health care, ﬁnancial protection against the cost of seeking care and
poverty alleviation strategies (L€onnroth et al., 2010). The post-2015School of Public Health and
niversity of Cape Town, Anzio
.
Ltd. This is an open access article ustrategy aims for ‘no affected families facing catastrophic costs due
to TB’ by 2025. Reducing the impact of the cost of illness is of
particular concern in TB control, due to the synergy between
poverty and TB disease. Poverty has been linked to a greater risk of
infection, poorer patient outcomes as well as affecting health-
seeking behaviour (Dye et al., 2009; Harris et al., 2011; Oxlade
and Murray, 2012; Spence et al., 1993; Wingﬁeld et al., 2014). In
addition, TB disease also worsens poverty by reducing patients'
physical strength and ability to work, ultimately leading to loss of
income (Daftary and Padayatchi, 2012; Goudge et al., 2009a). The
economic impact on the household is then further exacerbated by
the costs incurred while seeking health care (Whitehead et al.,
2001). In South Africa (SA), the economic burden of ill health onnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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incident cases of TB-HIV co-infection occur in SA, which roughly
equates to 530 000 people being infected with TB per annum
(Creswell et al., 2014; World Health Organisation, 2013).
Historically, studies seeking to quantify the ﬁnancial burden of
TB on patients have focused on the out of pocket costs measured at
a single point in time, with questions asked about retrospective
expenditures. This approach suffers from several limitations, in that
the measurement of cost is often not comprehensive, the economic
impact on patient's social networks is not captured, and there is
little insight provided on how patients adapt over time (Barter
et al., 2012). The costs typically measured, referred to as direct
costs, include transport costs to and from the health facility and any
costs for medication or consultation incurred by individuals while
seeking care. The magnitude of these direct costs is then compared
against the annual household income, individual income or the
household's expenditure on food (Ataguba, 2011). Various thresh-
olds for quantifying the level of direct cost that is likely to drive
households into poverty have been used, including 10% or 15% of
annual household or individual income, and 40% of household non-
food expenditure (Kawabata et al., 2002; Ranson, 2002;
Wyszewianski, 1986; Xu et al., 2003). Using these measures, pre-
vious TB costing studies have found that direct costs can be ‘cata-
strophic’ for many households and have called for further research
to identify households that are particularly at risk of catastrophic
expenditures (Barter et al., 2012; Mauch et al., 2011; Tanimura et al.,
2014; Ukwaja et al., 2012).
There is greater paucity in terms of the measurement of costs
associated with the time lost while being unable to work due to
seeking care, or being too ill to work. These so-called indirect costs
are used in an attempt to capture the productivity and economic
costs an individual or household incurs as a result of being ill or
spending time seeking treatment (Barter et al., 2012; Drummond
et al., 2007; Russell, 2004). There are several methods to value
time loss. The most common method is the Human Capital
Approach, which considers a set of marketable skills of workers as a
form of capital that is then used to produce an output, income for
the worker, and a contribution to the economy for society
(Johannesson, 1996; Tarricone, 2006). Following this approach, an
individual's time (or loss of productive time from treatment and
illness) is valued based on their productive output, in the form of
their reported income prior to being ill. This has equity implications
given that it excludes the value of time loss of those not employed
or looking after family at home. Alternative approaches include the
equality of wages method where time loss is valued equally across
individuals by using a proxy such as the minimum wage or the
average reported income for the cohort (Mauch et al., 2011;
Sinanovic et al., 2003). However, simply attaching a value of time
lost may not provide sufﬁcient insight into changes in income over
time, particularly the ability to recover income following a period of
illness; and they may not capture the broader impact to the
household, nor the ability of society to compensate any social
welfare lost (Koopmanschap et al., 1995).
Russell et al. made an important contribution to the under-
standing of costs of illness from a household perspective by high-
lighting the importance of and expanding the deﬁnition of
households' ‘ability to pay’ for health care to include the mobili-
zation of additional resources including borrowing from family
members, selling assets, forgoing consumption on other essential
commodities, or delaying payment (Russell, 1996). Longitudinal
household surveys suggest a heterogeneous economic impact of
health costs on households, with some households demonstrating
a resilience to high out of pocket costs while others are forced into
poverty by relatively small expenditures (Goudge et al., 2009b). In
SA, a longitudinal household study found that household resilienceagainst catastrophic costs was dependent on social support struc-
tures within communities, such as being able to borrow money
without interest, and someone to take over jobs or household tasks
or to care for an individual who is ill. Household resilience was
found to diminish as chronic illnesses, such as HIV, increased the
economic loss over time and jeopardised the long term welfare of
the family (Goudge et al., 2009a).
In SA, there are a limited number of studies that have estimated
the patient costs associated with TB care. Previous studies found
that direct costs and time spent accessing health care could be
substantial and that the cost of TB care varies between socio-
economic groups (Cleary et al., 2013; Floyd et al., 1997; Sinanovic
et al., 2003). However, these studies suffer from many of the
weaknesses highlighted above. They did not include the patient
costs prior to starting treatment, or examine in-depth how costs
and income changed over time.
We present a longitudinal study of the economic burden on
individuals and their social networks, from the start of TB symp-
toms to the end of treatment in SA. Indirect costs are estimated
using reported income loss and costs are presented by Socio-
Economic Status (SES), in order to explore how the economic
burden on patients and their social networks evolves as patients
negotiate their way through the healthcare system during the
course of TB illness.
2. Methods
2.1. Analytic framework
Economic burden (Fig. 1) was conceptualised by drawing on the
Access framework proposed by McIntyre et al. (2009) to examine
the interactions between individuals and the health system that are
likely to impact on patients' health seeking behaviour (McIntyre
et al., 2009). In terms of exploring the consequences of these in-
teractions, in addition to estimating the out-of-pocket costs
incurred by individuals, we examined reliance on social networks
to mediate a catastrophic ﬁnancial impact on the household
(Russell, 2004).
Social networks were deﬁned to include people from an in-
dividual's community who are able to take over job-related or
household related tasks while the individual is ill (‘carers’); to
accompany the patient to the clinic (‘guardians’); and being able to
borrow money without paying interest or receiving donations. The
availability of cash transfers and health insurance was also con-
ceptualised as a component of the patient's social network, which
could potentially alleviate some of the catastrophic consequences
of ill health.
2.2. Study design
To capture the economic impact of TB over time, and minimise
recall bias, a prospective cohort study of patient costs was con-
ducted as part of a cluster randomised pragmatic trial evaluating
the implementation of Xpert MTB/RIF in SA, the ‘XTEND’ trial. In-
terviews were conducted between July 2012 and June 2013. Con-
ducting a patient cost study as part of a trial offers the advantage of
having sufﬁcient infrastructure to follow patients up over time, but
can restrict sampling approaches. Fig. 2 provides a timeline of pa-
tients' trajectory through care seeking and treatment, the interview
time points and periods used in the analysis. These time points
were selected in order to co-ordinate with the main interview
points in the broader trial. As the trial was pragmatic, the aim was
to not inﬂuence the patient pathway to capture ‘real world’ con-
ditions and thus the frequency of interview was constrained.
The trial enrolled patients with symptoms suggestive of TB, who
Fig. 1. Dimensions of economic burden on individuals and households and interactions with the health system, adapted from Russell (2004) and McIntyre (2009).
Fig. 2. Timeline positioning data collection and time periods (A, B, and C) for patient cost analysis.
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comes (see Fig S1 and S2 in supplementary appendix). Only 10% of
those screened were projected to have TB. In order to capture the
pre-treatment costs, we sampled from those with symptoms
(Cohort 1). However, it was not possible to capture sufﬁcient
numbers of those with TB, given that enrolment was conducted
prior to the knowledge of whether a patient had TB, and due to the
expense of conducting a full questionnaire on high numbers of trial
participants. We therefore added a further cohort of TB patients
who were recruited from the same clinics for the economic study
alone (cohort 2), in order to fully capture the costs of those who
proceed to TB treatment.
In the cohort of those enrolled in the main trial (cohort 1), every
third trial participant enrolled at the sample sites was asked
additional questions regarding their health service use, the asso-
ciated costs experienced, as well as change in income from the start
of TB symptoms. Patients were eligible if they were older than 18
years of age, would be living in the area for the next eight months,
and were not currently on TB treatment. At the six-month follow
up, respondents were asked about their health service use and the
associated costs from the baseline visit to when they started TB
treatment or until the end of their TB associated symptoms (Fig. 2).
In cohort 2, TB patients were eligible if they were older than 18
years, had not been interviewed for the TB suspect cohort and had
started treatment approximately two months previously. At the TB
patient's enrolment interview, respondents were asked to report ontheir health service use and the associated costs in the last two
months. They were followed up three months later, and were asked
about costs incurred in the last month.2.3. Data collection
Ten public health clinics, in Gauteng, Mpumalanga, Eastern Cape
and Free State provinces were purposefully selected from the trial
sites to generate a representative sample of rural and urban sites,
facilities with different workloads, plus the location of the clinics
relative to the communities served. Clinic characteristics are
described in the supplementary appendix (see Table S3). Data were
captured using Epidata v3.1 and exported to STATA13 for analysis
(Lauritsen and Bruus, 2004; STATA Corporation, 2013). In order to
minimise recall bias, respondents were asked about the costs
incurred during their last visit; per period costs were then calcu-
lated by multiplying the cost per visit against the number of visits
reported during that period. Individual income was estimated by
asking detailed questions about income categories, including
formal employment, working from home, non-monetary pay-
ments, government grants, pension as well as infrequent or ‘piece’
work. Income from government grants and charity donations was
also explicitly unpacked. Furthermore, in order to assist re-
spondents in recalling what happened to them between enrolment
into the study and starting treatment, interviewers used a timeline
and anchored the questions to memorable events such as starting
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Socio-demographic and clinical characteristics of respondents in the suspects and
TB patient cohorts.
Suspects n ¼ 351 TB patients
n ¼ 175
Gender (% female)b 203 (58%) 78 (45%)
Mean age in years (median) 38 (36) 40 (39)
Self-reported HIV status (%)
HIV negative 88 (25%) 30 (17%)
HIV positive on ART 52 (15%) 79 (45%)
HIV positive 154 (44%) 33 (19%)
Unwilling to share status 57 (16%) 33 (19%)
Educational statusa,c (%)
No formal education 256 (73%) 120 (69%)
School leavers' certiﬁcate 81 (23%) 49 (28%)
Tertiary education 13 (4%) 1 (0.6%)
Reported primary source of incomed (%)
Formal employment 86 (25%) 40 (23%)
Odd jobs 52 (15%) 23 (13%)
Self-employed 20 (6%) 9 (5%)
Maintenance 4 (2%) 1 (0.6%)
Pensioner 15 (4%) 5 (3%)
Government grant 41 (12%) 37 (21%)
Student 12 (3%) 3 (2%)
No income 121 (34%) 55 (31%)
a No formal education deﬁned as all respondents without a high school leavers
certiﬁcate.
b 2 non responses in the TB patients cohort.
c 1 non response in the TB suspects cohort and 5 in the TB patients cohort.
d 2 non responses in the TB patients cohort.2.4. Data analysis
Costs incurred were analysed for three time periods (See Fig. 2),
from the start of TB-associated symptoms to the initiation of TB
treatment for those who did start treatment (A) or until the
amelioration of symptoms for those who did not start treatment.
Followed by, for TB patients, the time from the start of treatment to
the end of the intensive phase at 2 months (B), and the time during
continuation phase of treatment (C). The dataset for analysis was
restricted to respondents where a follow up interview was con-
ducted and responses from patients who passed away or were lost
to follow up were not included. In addition, those who were
symptomatic but did not start TB treatment were analysed sepa-
rately, and are presented in the results as a comparison.
For each of the time periods described in Fig. 2, the direct and
indirect costs incurred by people with suspected TB and those on
treatment were calculated. Direct costs were calculated by adding
the cost of travel to and from facilities, admission or consultation
costs, the cost of medication and/or food while admitted, and any
fees paid in lieu of diagnostic procedures. In each time period the
overall cost was calculated by multiplying the number of visits by
the cost per visit for the time period. Indirect costs were calculated
based on the reported income loss due to TB symptoms and/or
treatment. Finally, in order to explore the broader impact of the
individual's illness on the economic costs households faced, social
resources were assessed by estimating the costs to adults accom-
panying the respondent to the clinic, time spent caring for or taking
over the tasks of the individual who is ill, as well as money bor-
rowed to cover costs (Mauch et al., 2011; Russell, 1996). The op-
portunity costs of these ‘carers’ and ‘guardians’ were calculated by
multiplying time spent by the average income of respondents prior
to the start of symptoms.
Due to the uneven distribution of costs with a minority of re-
spondents reporting high costs, mean and median values were
reported for all cost estimates as measures of central tendency and
Standard deviation (SD) and inter-quartile ranges (IQR) were re-
ported (Glick et al., 2010). To assess differences in costs between
groups, p-values were calculated using non-parametric methods,
two-sample Wilcoxon rank-sum test and the KruskaleWallis test.
Logistic regressions were run to identify patient and health service
drivers of both income loss (1 ¼ yes; 0 ¼ no), and ‘catastrophic’
costs (1 ¼ more than 10% of annual individual income; 0 ¼ no).
Costs were converted to United States Dollars (US$) using the 2013
average annual exchange rate of US$1 ¼ R9.62. (www.Oanda.com).
As a measure of individuals' ability to pay for out-of-pocket
expenses, we compared direct costs incurred against annual indi-
vidual income and deﬁned costs as catastrophic if they exceeded
10% of individual income (Ranson, 2002). Where individuals were
earning no income, we performed a separate analysis, imputing an
annual income of US$1 when calculating catastrophic costs. This
approach was presented separately to highlight the burden on
households with no incomes (Ataguba, 2011). A range of household
measures of SES were collected and an asset index was created
using Multiple Correspondence Analysis (MCA). Variables used to
created the asset index included type of house, material of walls,
ﬂoors, type of water supply and toilet, possession of a bicycle or a
car, as well as other assets such as an electric stove, radio, and
livestock. MCA as opposed to Principal Components Analysis (PCA)
was used to create the asset index as MCA makes fewer assump-
tions about the underlying distributions of indicator variables and
is more suited for the analysis of categorical variables (Booysen
et al., 2008; Howe et al., 2008; Traissac and Martin-Prevel, 2012).2.5. Ethics
The human research ethics committees at the University of Cape
Town (363/2011), University of the Witwatersrand (M110827),
London School of Hygiene and Tropical Medicine (6041), and the
World Health Organisation (RPC462) granted ethical approval for
the study in November 2011. Health department ofﬁcials and fa-
cility managers provided permission to conduct the study in the
selected facilities and written informed consent was obtained from
respondents.
3. Results
A total of 618 respondents were interviewed. In the ﬁrst cohort,
385 respondents were enrolled, 23 died prior to the follow up
interview and 11 were Lost to follow-up (LTFU). Of the 351 re-
spondents remaining, 37 had a positive diagnostic test and a total of
45 were started on ﬁrst line TB treatment, three on retreatment and
one on MDR TB treatment. In the TB patient cohort, 233 TB patients
were enrolled at the two-month change of treatment phase, 5 died
and 53 were LTFU. Direct costs incurred at enrolment were not
signiﬁcantly different between those retained in the study and
those not (p ¼ 0.605; p ¼ 0.269).
3.1. Sample and setting characteristics
Of those interviewed, 45% were in rural and 55% in urban set-
tings. Within study clinics, a mix of facility based e and self-
observed TB treatment was provided with varying levels of
community-based support (see supplementary Table S3). Table 1
presents the respondent characteristics.
The level of education in the sample population was lower than
the general SA population, with 4% of respondents with post school
education, compared to 12%. Similarly, the unemployment rate at
47% and 54% respectively was higher than the overall SA unem-
ployment rate of 30% (Statistics South Africa, 2012). Of the re-
spondents, 12% and 21% respectively listed government grants as
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relied on odd jobs or self-employment as their primary source of
income. Only 34% and 38% of respondents indicated that other
household members had a steady job. Levels of private health in-
surance were low in both cohorts (1% and 4%). When compared
against the national statistics, these ﬁndings suggest that the re-
spondents were particularly poor relative to the average South
African household (Statistics South Africa, 2012).3.2. Costs associated with health service use
During the symptomatic period, the median time from experi-
encing symptoms to getting a TB test was 21 days, and in thosewho
started treatment, the median time from test to treatment was 1
day. There was a statistically signiﬁcant difference in the time with
symptoms between poor and less poor patients (p < 0.05). In those
who started treatment, the mean time from ﬁrst symptom to TB
test was 90 days in the poorest group compared to 33 days in the
less poor group. Respondents' ﬁrst port of call when experiencing
symptoms was their local public clinic (80%) and patients made a
mean of two visits to the public clinic. During the two-month
intensive phase of treatment, a mean number of 12 (and a me-
dian of four) visits were made followed by 12 (and a median of
eight) during the four-month continuation phase of treatment.
Patients were collecting TB medication weekly or even monthly as
opposed to daily Directly Observed Treatment (DOTS). Just under
half of those in the TB patient cohort (45%) were HIV positive and
on Anti-Retroviral Therapy (ART) but only 24% of those on ARTwere
able to collect their TB medication and ART during the same clinic
visit. Reported utilisation of traditional health care workers was
very low (1%).
In Table 2, the direct costs incurred are presented and compared
to respondents' annual individual income. This is followed by
direct, indirect and total societal costs in Table 3. The mean total
direct costs incurred by respondents in accessing health care during
TB diagnosis and treatment were US$111.83 or 12% of annual in-
dividual pre-symptom income and 53% of the total episode patient
cost. The largest share of the direct costs was incurred during the
pre-diagnosis and diagnosis phase. Direct costs were likely low
given that TB care is provided free at primary health care clinics in
SA and the majority of respondents (61% and 66% respectively)
were able to walk to the clinic to access care. Of the total direct
costs, nutritional supplements - especially during the pre-
diagnostic and diagnosis phase - were a substantial cost, with re-
spondents spending an average of US$12.54 during the symptom-
atic period. People Living With HIV and AIDS (PLWHA) spent
signiﬁcantly more on supplements (US$9.37) than those who were
HIV negative (US$5.35) (p < 0.05) which may reﬂect the emphasis
placed on healthy diets during HIV/TB counselling. The costs
associated with someone accompanying the respondent to theTable 2
Pre-treatment and treatment direct costs (2013 US$).
Period Sample
size
Non-transport
direct costs
Direct
transport costs
Time loss
(hours), m
Mean Median Mean Median
Pre-diagnosis & diagnostic 49 22.73 0.00 10.55 0.00 9
Treatment (intensive) 175 29.80 0.00 4.33 0.00 59
Treatment (continuation) 175 17.96 0.00 11.58 0.00 31
Total episode cost 70.49 0.00 26.46 0.00 99
No TB 302 17.63 0.00 6.04 0.00 14
a Mean monthly individual income prior to the start of TB-associated symptoms.
b Percentage of mean annual individual income prior to the start of TB-associated symhealth facility (guardian costs) were greatest during the intensive
phase of treatment. Similarly, the cost of someone to either take
over the respondent's tasks or to look after them was greatest
during the intensive and continuation phases of treatment.
Once patients start TB treatment, we found that poor patients
were spending a greater percentage of their annual income on costs
associated with seeking care than those who are less poor. The
poorest group of patients were incurring higher direct costs, with
fewer resources to pay for it.3.3. Income loss
The mean monthly individual income of the entire cohort prior
to starting symptoms was US$103.12. Income prior to symptoms
was considerably different between those who started TB treat-
ment compared to those who did not, US$76.05 and US$107.51
respectively. Prior to symptoms, 59% of individuals in the cohort
reported no income; this proportion was higher in the group that
started TB treatment (69%).
Income loss was signiﬁcantly higher in those who didn't start TB
treatment (p < 0.05) - but probably points to the higher percentage
of those with no income (and hence no possible income loss) in the
group that starts TB treatment (Table 5). In addition, income loss
was higher in rural communities and there was some protective
effect in those receiving non-productive income such as govern-
ment grants. The greatest share of income loss occurred in the
period between the start of symptoms and starting TB treatment.
During the intensive phase of treatment, there is a further net loss
of income that is possibly tempered due to an income gain expe-
rienced by some individuals. During the continuation phase we see
a small net loss that does suggest that individuals who had the
initial loss of incomemay not regain income as quickly as wemight
have expected.
3.4. Coping costs and impact on social networks
In trying to understand the broader impact of ill health, direct
costs and income loss, we explored the impact on social networks.
The percentage of patients who employ coping strategies and ac-
cess social resources are shown in Fig. 3.
About 22% of those with TB compared to 8% of those without TB
reported relying on carers, either in the form of someone to take
over their job or household duties or to look after them prior to
starting and during treatment, and 5% of patients reported selling
assets. We found that few patients (3%) were accessing cash
transfers (in the form of the disability grant) during the intensive
phase of treatment with a subsequent slight increase (to 5%) during
the continuation phase of treatment. This may reﬂect the time it
takes from application to receiving the grant and suggests a lack of
access to grants. We explored factors associated with incurringean
Cost of
nutritional
supplements
Total direct
costs, mean
Monthly income, meana Percentage of
annual incomeb
Mean Median
12.54 0.00 45.82 76.05 5%
1.10 0.00 35.23 76.05 4%
1.24 0.00 30.78 76.05 3%
14.88 0.00 111.83 76.05 12%
6.26 0.00 29.93 107.51 2%
ptoms.
Table 3
Pre-treatment and treatment indirect and total costs (2013 US$).
Period Sample size Total direct
costs, mean
Loan interest,
mean
Reported
income loss
Total cost to
the patient, mean
Percentage of
annual income
Guardian costs,
mean
Carer costs,
mean
Total cost, mean
Mean Median
Pre-diagnosis & diagnostic 49 45.82 0.64 39.26 0.00 85.72 9% 7.46 1.94 95.12
Treatment (intensive) 175 35.23 6.57 15.56 0.00 57.36 6% 22.99 39.10 119.45
Treatment (continuation) 175 30.78 36.11 0.00 0.00 66.89 7% 1.66 40.95 109.50
Total episode cost 111.83 43.32 54.82 0.00 209.97 22% 32.11 81.99 324.07
No TB 302 29.93 0.34 62.13 0.00 92.40 7% 5.49 1.93 99.82
If we explore the costs incurred by SES, we ﬁnd that the least poor group were spending a greater percentage of their annual income than those in the poorer group during the
pre-diagnostic period. This can be explained by more visits to private health care facilities (see Table 4).
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Not surprisingly, we found that those who reported that their
main source of income was through formal or self-employment, as
compared to those with no income, were less likely to experience
catastrophic expenditure. During the diagnostic phase, the number
of symptoms and health care visits were signiﬁcant factors in
catastrophic expenditure. In both the diagnostic and treatment
phase the amount spent on nutritional supplements increased
catastrophic expenditure.4. Discussion
The study found that the cost of TB diagnosis and treatment in
SA could be catastrophic and drive the ‘medical poverty trap’. For
those starting on treatment, the costs associated with a TB episode
totalled 22% of the average pre-symptoms individual income. The
greatest ﬁnancial cost was incurred in the time between ﬁrst
becoming symptomatic and starting treatment. A similar trend was
found in other patient cost studies where pre-treatment and
treatment costs were included (Tanimura et al., 2014; Vassall et al.,
2010). This was compounded by the income loss experienced prior
to treatment, which made up 72% of the total episode income loss
and 26% of the total episode cost. This is signiﬁcant given that 59%
of respondents reported no income prior to symptoms. Where we
used a proxy to compare costs against a nominal income of US$1
per annum, the percentage of costs against income is seen to far
exceed income which suggests that those with no income are
experiencing excessive out-of-pocket costs, placing a signiﬁcant
burden on households given that only approximately a third of
respondents indicated that another household member had a
steady job.
Geographical access to health facilities was good, with few re-
ported visits to private health facilities or Traditional Health Prac-
titioners (THP) before receiving a TB test. Only 3% of respondents
reported visits to THP, this is possibly underreported due to social
desirability bias (Nxumalo, 2011). While the relatively low levels of
direct costs were encouraging, we found that for many patients
these small expenses were nevertheless catastrophic given that
many patients reported no income. Where individuals did report
having an income, income loss when patients started experiencing
TB symptoms was high and may have been inﬂuenced by a lack of
the protective effects of sickness beneﬁts and leavewhen employed
in the informal sector.
Given that the number of health care visits was a signiﬁcant
factor in determining catastrophic expenditure, the South African
Department of Health's policy on reducing the number of visits to a
health facility during TB treatment has alleviated some of the
economic burden (Republic of South Africa Department of Health
(2009)). However, without proper support, a reduction in visits
may have consequences for adherence and future drug resistance.
The system of TB treatment through community-based care hasbeen shown to be cost-effective and has been policy for many
years; but has yet to be implemented in a comprehensive manner
(Sinanovic et al., 2003). Further effort should bemade to strengthen
and implement this policy.
Coping strategies and social networks triggered by these
ﬁnancial stresses were activated in a cascade. During the symp-
tomatic and intensive phase of treatment, patients were relying on
guardians and carers for assistance, and borrowing money was
greatest during the intensive phase of treatment. Conversely, up-
take of cash transfers only occurred during the continuation phase
of treatment when the economic burden on individuals was at its
lowest. In SA, a short-term cash transfer, called the disability grant
is provided to individuals if they are deemed to be unable to work
as a result of a physical disability. Access to these grants is however
limited as patients have to see a dedicated doctor who is not based
at the clinic (personal communication, South African Social Security
Agency). This is reﬂected in our results, with only 5% of respondents
receiving a disability grant. The percentage of patients selling assets
increased between the pre-treatment period and the continuation
phase of treatment, as ﬁnancial losses over time depleted house-
hold as well as social resources (Goudge et al., 2009a). The pro-
portion of patients borrowing money and selling assets was similar
to what was found in another South African study (Cleary et al.,
2013).
The study had a number of limitations. Firstly, recall bias is a
particular concern in patient cost surveys. Although we have
improved upon previous methods by conducting a longitudinal
study, a balance had to be found between ensuring the ‘pragmatic’
nature of the research setting was retained and recall bias. We
attempted to limit the negative effect of recall bias by linking
questions about costs incurred to ‘memorable’ events such as
starting treatment or the start of symptoms. A second limitation of
the study is that even though we attempted to capture the inﬂu-
ence on social networks, assessing the impact on the household
through patient - rather than household surveys may not fully
capture household impact. For example, it was not possible to
collect accurate household income data, and by comparing the
direct costs incurred against annual individual income, we might
have underestimated the burden of the cost given that individual
income is likely to be shared among members of a household. It is
also possible that household members would share their income
with the respondent, although this effect may be small as only a
third of respondents reported that another family member had a
steady job. In addition, the impact of a single disease was studied
and further research should be done to estimate the economic
burden to patients with multiple chronic diseases especially co-
infection with HIV and TB. And lastly, due to the nature of the
study, we were only able to interview those who, by deﬁnition,
were able to access health services. It is therefore possible that we
are underestimating the access barriers due to out of pocket cost
and income losses. Although the ﬁndings are limited in the sense
Table 4
Costs incurred (2013 US$), presented by SES and over time.
Pooresta Least poora p-value
Mean Median Mean Median
Pre-diagnosis & diagnostic period in those who start TB treatment: represents a mean of 45 days (n ¼ 49)
Public health facility visits, number of 3 3 3 3 0.845
Private health facility visits, number of 0 0 1 0 <0.05
Total direct costs 24.35 0.00 55.57 17.36 0.173
Direct costs as % of annual individual income 1% 0% 6% 1% 0.346
Adjusted costs as % of incomeb 1000% 0% 3323% 2% 0.137
Time loss, number of hours 5 2 11 2 0.236
Reported income loss 50.86 0.00 67.25 0.00 0.539
Guardian costs 0.00 0.00 11.07 0.00 <0.05
Carer costs 1.46 0.00 2.15 0.00 0.620
Total costs 76.67 38.61 136.04 66.73 0.501
Intensive treatment phase: represents a two month period (n ¼ 175)
Public health facility visits, number of 15 4 11 4 0.885
Private health facility visits, number of 0 0 0 0 0.515
Total direct costs 52.88 0.00 17.11 0.00 <0.05
Direct costs as % of annual individual income 3% 0% 3% 0% 0.812
Adjusted costs as % of incomeb 1514% 0% 285% 0% <0.05
Time loss, number of hours 62 21 44 15 0.412
Reported income loss 12.17 0.00 19.00 0.00 0.995
Guardian costs 17.35 0.00 18.97 0.00 0.609
Carer costs 18.14 0.00 32.67 0.00 0.362
Total costs 100.54 11.66 87.75 0.00 0.059
Continuation treatment phase: represents a four month period (n ¼ 175)
Public health facility visits, number of 14 8 14 8 0.222
Private health facility visits, number of 0 0 0 0 0.196
Total direct costs 48.18 0.00 13.18 0.00 <0.05
Direct costs as % of annual individual income 3% 0% 3% 0% 0.859
Adjusted costs as % of incomeb 3791% 0% 1183% 0% <0.05
Time loss, number of hours 35 14 25 12 0.332
Reported income loss 0.00 0.00 0.00 0.00 0.315
Guardian costs 3.08 0.00 0.22 0.00 0.405
Carer costs 1.98 0.00 5.38 0.00 0.627
Total costs 53.23 0.00 17.58 0.00 <0.05
Total episode costs 230.44 50.27 241.37 66.73
No TB (n ¼ 302)
Public health facility visits, number of 3 2 3 2 0.089
Private health facility visits, number of 1 0 1 0 0.096
Total direct costs 26.53 0.00 33.50 0.00 0.296
Direct costs as % of annual individual income 878% 0% 1800% 0% 0.168
Adjusted costs as % of incomeb 1% 0% 4% 0% 0.418
Time loss, number of hours 14 2 15 1 0.281
Reported income loss 82.00 0.00 109.80 0.00 0.849
Guardian costs 7.69 0.00 2.86 0.00 0.894
Carer costs 2.25 0.00 1.52 0.00 0.973
Total costs 118.47 25.85 147.68 16.00 0.788
Note: Standard errors are not reported here due to space considerations.
a The poorest group is represented in the lowest asset index tertile, and the least poor group is represented in the upper tertile.
b In the adjustment for those with no income, we assumed an annual income of US$1 in all with no income.
Table 5
Logistic regression exploring drivers of income loss while symptomatic (n ¼ 351).
Income loss (1 ¼ yes) OR (95% CI)a p-value
Gender (1 ¼ male) 0.66 (0.35; 1.24) 0.196
Years of education 1.03 (0.93; 1.14) 0.609
HIV status 0.88 (0.57; 1.36) 0.566
Bacteriologically conﬁrmed TB (1 ¼ positive) 0.31 (0.10; 0.92) <0.05
Rural (1 ¼ rural) 4.52 (2.18; 9.39) <0.05
Main income source ¼ formal employment reference
Main income source ¼ self employed 1.34 (0.42; 4.27) 0.616
Main income source ¼ odd jobs 0.73 (0.32; 1.67) 0.462
Main income source ¼ non-productive income 0.02 (0.01; 0.06) <0.05
Main income source ¼ no income 0.03 (0.01; 0.07) <0.05
Days symptomatic 1.00 (0.99; 1.00) 0.059
Other HH member steady job 0.80 (0.39; 1.61) 0.525
Asset index (1 ¼ least poor) 0.80 (0.56; 1.13) 0.202
Number of health care visits 1.07 (0.99; 1.15) 0.106
Pseudo R2 ¼ 3948
a
N. Foster et al. / Social Science & Medicine 130 (2015) 42e5048that they are pertinent to SA, the general approach used by this
study could be applied to other settings; in particular the use of
longitudinal data, the measurement of income loss and including
the costs to societal networks.
Nevertheless, some important policy recommendations can be
made. Firstly, it is clear that the social protection scheme as it
currently stands is not sufﬁcient to alleviate the poverty impact of
TB and prevent TB by minimising poverty. It was encouraging to
ﬁnd that the majority of patients' ﬁrst point of call when ill was a
public clinic, and that patients were largely able to walk to a health
facility. However, even though TB services are provided free of
charge, patients are incurring catastrophically high costs. Many
patients had little or no income with which to pay for these costs.
The social protection currently provided comes in too late.
Although there have been calls to reduce the ‘holes’ in the social
protection safety net in SA, this remains a long-term solution
(Peters, 2014). More comprehensive social protection programs,
that cover more than just the direct costs of care but also allow forOR ¼ odds ratio; 95% CI ¼ 95 percent conﬁdence interval.
Fig. 3. Percentage (%) of respondents using coping strategies by type.
Table 6
Regression exploring relationship between ‘catastrophic’ health care related expenditure (>10% of annual individual income) and key socio-economic and related factors.
Variable Diagnostic period p-value Treatment period p-value
OR (95% CI) OR (95% CI)
Gender (1 ¼ male) 1.20 (0.69; 2.10) 0.521 0.35 (0.17; 0.73) <0.05
Rural (1 ¼ rural) 0.98 (0.53; 1.81) 0.950 2.67 (1.22; 5.85) <0.05
TB (1 ¼ positive) 1.28 (0.60; 2.75) 0.528 e e
Number of symptoms 1.18 (1.02; 1.36) <0.05 e e
Number of health care visits 1.10 (1.01; 1.21) <0.05 0.99 (0.98; 1.01) 0.242
Main source of income ¼ No income reference reference
Main source of income ¼ Formal 0.17 (0.07; 0.40) <0.05 0.34 (0.12; 0.98) <0.05
Main source of income ¼ Self-employed 0.22 (0.05; 0.97) <0.05 0.70 (0.14; 3.59) 0.670
Main source of income ¼ Odd jobs 0.66 (0.30; 1.46) 0.304 0.46 (0.14; 1.56) 0.213
Main source of income ¼ Government grant 1.23 (0.58; 2.61) 0.584 1.04 (0.41; 2.60) 0.937
Asset index (1 ¼ least poor) 1.26 (0.69; 2.28) 0.453 0.67 (0.31; 1.47) 0.315
Years of schooling 1.01 (0.93; 1.10) 0.837 1.01 (0.90; 1.12) 0.926
Amount spent on nutritional supplements 1.00 (1.00; 1.01) <0.05 1.12 (1.02; 1.24) <0.05
Pseudo R2 ¼ 0.1651 Pseudo R2 ¼ 0.1959
N. Foster et al. / Social Science & Medicine 130 (2015) 42e50 49better nutrition and prevent households from being further
impoverished by illness are needed. In the short term, the priority
for poverty focused TB services must be the early detection of TB.
Many of those with TB are currently in HIV care, and therefore
policies supporting intensive case ﬁnding in these groups may have
a poverty alleviating impact. For those accessing general health
services, integration of TB screening into primary health care ser-
vices would be beneﬁcial. Once on treatment, providing treatment
and support in the community would reduce the impact of TB on
household members especially during the intensive phase of
treatment. Access to the current disability grant could be improved
by removing the need for assessment by a doctor.5. Conclusions
People with suspected TB and those on TB treatment were fol-
lowed up over a sustained time period to examine the economic
burden of TB in SA. The results highlight the importance of
including those with no incomes in the analysis and the mismatch
between the need and availability of social protection for those
with TB. In particular, we found that respondents incurred high
economic losses prior to diagnosis and that income loss was severe.
Both national and global policy recommendations should therefore
focus on ensuring that health systems identify those with TB early
on, support those on treatment with TB in a way that minimisesincome loss, and provide social protection to those with the lowest
income if we are to break the vicious cycle between TB and poverty
for those living in deprived circumstances.Acknowledgements
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